Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 5/20 | 0.48 |
| ▸ | MTNR1B | P49286 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | METAP2 | P50579 | 7/20 | 0.44 |
| ▸ | METAP1 | P53582 | 6/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylamine SCHEMBL27536507 | 0.92 | MTNR1A (0.47) | MTNR1AMTNR1BALDH1A1L3MBTL1MAPT | |
| SCHEMBL27566696 | 0.92 | PARP10 (0.53) | MTNR1AMTNR1BMAPTTSHREPHX1 | |
| SCHEMBL27468317 | 0.92 | METAP2 (0.50) | MTNR1AMTNR1BALDH1A1L3MBTL1MAPT | |
| Phenol SCHEMBL28099048 | 0.92 | MTNR1A (0.43) | MTNR1AMTNR1BALDH1A1L3MBTL1MAPT | |
| SCHEMBL10506141 | 0.88 | KMT2A (0.45) | MTNR1AMTNR1BALDH1A1MAPTHSD17B10 | |
| SCHEMBL26805580 | 0.83 | METAP2 (0.42) | MTNR1AMTNR1BALDH1A1L3MBTL1MAPT | |
| SCHEMBL3590919 | 0.81 | METAP2 (0.46) | METAP2METAP1TSHR | |
| SCHEMBL3069934 | 0.80 | SMN1; SMN2 (0.52) | ALDH1A1MAPTMETAP2METAP1TSHR | |
| SCHEMBL29852923 | 0.80 | MEN1 (0.48) | ALDH1A1MAPTTSHRCYP3A4 | |
| SCHEMBL4057878 | 0.80 | TDP1 (0.46) | ALDH1A1MAPTTSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115124542-A | Synthetic method of hydroxyphenyl-substituted pyrazolone indazole [ spiro ] pyrazolone compound | 河南师范大学 | 2022-09-30 | — | — | CN | claimed |
| CN-115028645-A | Synthesis method of bisindolone [ spiro ] benzodihydrofuran compound | 河南师范大学 | 2022-09-09 | — | — | CN | claimed |
| CN-110372651-A | A kind of synthetic method of the indene derivative of the skeleton containing benzofuran | 上海师范大学 | 2019-10-25 | — | — | CN | claimed |
| CN-110033745-A | A kind of guitar backplate and its processing method | 吴东山 | 2019-07-19 | — | — | CN | claimed |
| CN-109734618-A | A kind of preparation method and phenoxy acetamide class compound of phenoxy acetamide class compound | 宜春学院 | 2019-05-10 | — | — | CN | claimed |
| CN-103694197-B | Phenoxyacetamide compound and preparation method and application thereof | UNIV HUAZHONG NORMAL | 2015-07-15 | — | — | CN | claimed |
| CN-103694197-A | Phenoxyacetamide compound and preparation method and application thereof | UNIV HUAZHONG NORMAL | 2014-04-02 | — | — | CN | claimed |
| EP-2643000-A2 | THERAPEUTIC PIPERAZINES | Dart Neuroscience (Cayman) Ltd (KY) | 2013-10-02 | — | — | EP | claimed |
| WO-2012040258-A2 | THERAPEUTIC PIPERAZINES | HELICON THERAPEUTICS, INC. (US) | 2012-03-29 | — | — | WO | claimed |
| US-20110065691-A1 | THERAPEUTIC PIPERAZINES | DART NEUROSCIENCE (CAYMAN) LTD. (KY) | 2011-03-17 | — | — | US | claimed |
| EP-1299377-A2 | SPLA2 INHIBITORS | ELI LILLY AND COMPANY (US) | 2003-04-09 | — | — | EP | claimed |
| WO-2002000641-A2 | SPLA2 INHIBITORS | ELI LILLY AND COMPANY (US) | 2002-01-03 | — | — | WO | claimed |
| US-5475139-A | Molecular rearrangement, aminolysis of n-phenylphenoxy acetamide and metallic phenol salt | YUNG SHIN PHARM. IND. CO., LTD. (TW) | 1995-12-12 | — | — | US | claimed |
| EP-4370508-B1 | TRIAZOLE COMPOUNDS FOR THE CONTROL OF INVERTEBRATE PESTS | BASF SE (DE) | 2025-09-10 | — | — | EP | disclosed |
| US-20250214984-A1 | COMPOUND HAVING KDM5 INHIBITORY ACTIVITY AND PHARMACEUTICAL USE THEREOF | ONO PHARMACEUTICAL CO., LTD. (JP) | 2025-07-03 | — | — | US | disclosed |
| EP-4146645-B1 | 3-AZABICYCLO(3.1.0)HEXANE DERIVATIVES HAVING KDM5 INHIBITORY ACTIVITY AND USE THEREOF | ONO PHARMACEUTICAL CO (JP) | 2025-06-25 | — | — | EP | disclosed |
| EP-0128029-A2 | Cephalosporin ester derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1984-12-12 | — | — | EP | disclosed |
| EP-0128027-A2 | Cephalosporin esters, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1984-12-12 | — | — | EP | disclosed |
| EP-0051261-A1 | Process for the production of discharge-resist prints on textile materials | CASSELLA Aktiengesellschaft (DE) | 1982-05-12 | — | — | EP | disclosed |
| US-4291060-A | Compounds derived from formylphenoxyacetic acid as antiviral agents in animals | PFIZER INC. (US) | 1981-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250214984-A1 | COMPOUND HAVING KDM5 INHIBITORY ACTIVITY AND PHARMACEUTICAL USE THEREOF | KDM5A, KDM5B, KDM5D | MTNR1A 2547/4885MTNR1B 3092/4885ALDH1A1 2221/4885 |
| US-20110065691-A1 | THERAPEUTIC PIPERAZINES | PDE4A, PDE4B, PDE4D | MTNR1A 624/4885MTNR1B 641/4885ALDH1A1 1228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.